Back to search

A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma

Data up to Jan 2025

Published1992
Citations373
References13

Total Citations Per Year

Abstract

References (13)

Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma

1987 • 2,165 citations

Regular inhaled beta-agonist treatment in bronchial asthma

1990 • 1,090 citations

Pulmonary Function Testing in Children. Techniques and Standards

1973 • 787 citations

A New Approach to the Treatment of Asthma

1989 • 458 citations

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.

1988 • 280 citations

Protection against allergen-induced asthma by salmeterol

1990 • 237 citations

Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

1991 • 182 citations

Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.

1990 • 173 citations

Inhaled Salmeterol and Salbutamol in Asthmatic Patients: An Evaluation of Asthma Symptoms and the Possible Development of Tachyphylaxis

1990 • 164 citations

The pathogenesis and significance of bronchial hyper-responsiveness in airways disease

1987 • 116 citations

Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease

1991 • 91 citations

Regular versus symptomatic aerosol bronchodilator treatment of asthma

1981 • 55 citations

Salmeterol, a new inhaled beta-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction

1992 • 52 citations

Cited By (0)

No citing papers found in database

A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma (1992) – New England Journal of Medicine | Metascience Observatory Explorer